Suppression of CYP2C9 is closely correlated with the progression of HCC [40,41], and downregulation of CYP2C9 expression by hsa-miR-128-3p results in tumor cell invasion in HCC [42]. The gene discussed is CYP2C9; the disease is hepatocellular carcinoma.